4 Analysts Have This to Say About Spero Therapeutics
Portfolio Pulse from Benzinga Insights
In the last quarter, Spero Therapeutics (NASDAQ:SPRO) received four bullish ratings from analysts. The average price target for the stock is $6.5, which is significantly higher than its current price of $1.405. This average price target has increased by 8.33% from the previous average of $6.00.
September 05, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Spero Therapeutics received four bullish ratings from analysts, with an average price target of $6.5, indicating a potential upside.
The bullish ratings and the significantly higher average price target suggest that analysts are optimistic about Spero Therapeutics' stock performance in the short term. This could potentially drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100